PLUS THERAPEUTICS, INC.

Over the last 90 days, Plus Therapeutics (PSTV) has generated zero cyber incidents and zero red-flag 8-K filings—no bankruptcies, delistings, restatements, or officer departures detected in our real-time pipeline. However, low signal in a 90-day window does not mean low risk; the full Report extends analysis to 12 months of filing history and adds critical context on dilution trajectories, financing activities, and AI-detected stress signals that shape the real risk profile. The full $49 Report adds quantified dilution risk scoring, 8-K pattern analysis, 12-month financing history, and AI anomaly detection across executive moves and regulatory filings.